Skip to content

Clinical trials

Phase 3 Multiple Myeloma trials in Russia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Multiple Myeloma Phase: Phase 3 Country / region: Russia Clear all

38 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20041
20092
20102
20113
20122
20133
20143
20151
20162
20176
20181
20192
20204
20211
20221
20231
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed25
Active, not recruiting8
Terminated3
Recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen7
Janssen Research & Development, LLC7
Celgene4
AbbVie3
GlaxoSmithKline3
Sanofi3
Biocad2
Oncopeptides AB2
AEterna Zentaris1
Bristol-Myers Squibb1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Multiple Myeloma38
Recurrence6
Neoplasms, Plasma Cell4
Neoplasms3
Blood Protein Disorders1
Bone Diseases1
Bone Marrow Diseases1
Bone Marrow Neoplasms1
Bone Neoplasms1
Fractures, Bone1

Trials

Showing 1 to 25 of 38. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.